Company Acerus Pharmaceuticals Corporation Toronto S.E.
Equities
ASP
CA00444G4051
Pharmaceuticals
Business Summary
Number of employees: 14
Managers
Managers | Title | Age | Since |
---|---|---|---|
Edward Gudaitis
CEO | Chief Executive Officer | - | 01/18/01 |
Naveed Manzoor
DFI | Director of Finance/CFO | - | - |
Chief Tech/Sci/R&D Officer | - | 17/20/17 | |
Philippe Savard
LAW | General Counsel | - | 04/16/04 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | - | |
Ian Ihnatowycz
CHM | Chairman | 71 | 09/13/09 |
Borys Chabursky
BRD | Director/Board Member | - | 20/15/20 |
Edward Gudaitis
CEO | Chief Executive Officer | - | 01/18/01 |
Stephen Gregory
BRD | Director/Board Member | - | 14/11/14 |
Geoff Cotton
BRD | Director/Board Member | - | 01/20/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 7,702,297 | 662,312 ( 8.599 %) | 0 | 8.599 % |
Company contact information
Acerus Pharmaceuticals Corp.
7025 Langer Drive Suite 205
L5N 0E8, Mississauga
+
http://www.aceruspharma.comSector
1st Jan change | Capi. | |
---|---|---|
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |